US Stock MarketDetailed Quotes

Jazz Pharmaceuticals (JAZZ)

Watchlist
  • 171.000
  • +1.840+1.09%
Close Jan 22 16:00 ET
  • 171.000
  • 0.0000.00%
Post 18:03 ET
10.39BMarket Cap-27.76P/E (TTM)

Jazz Pharmaceuticals (JAZZ) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
6.74%1.13B
2.14%1.05B
-0.46%897.84M
6.12%4.07B
7.53%1.09B
8.52%1.05B
6.95%1.02B
1.03%901.98M
4.78%3.83B
4.10%1.01B
Operating revenue
6.74%1.13B
2.14%1.05B
-0.46%897.84M
6.12%4.07B
7.53%1.09B
8.52%1.05B
6.95%1.02B
1.03%901.98M
4.78%3.83B
4.10%1.01B
Cost of revenue
15.47%128.88M
5.79%116.27M
9.56%104.62M
2.33%445.71M
20.02%128.71M
9.26%111.61M
12.68%109.9M
-25.77%95.49M
-19.41%435.58M
-35.92%107.24M
Gross profit
5.71%997.23M
1.70%929.44M
-1.65%793.22M
6.61%3.62B
6.05%959.46M
8.43%943.36M
6.30%913.92M
5.54%806.5M
8.97%3.4B
12.42%904.69M
Operating expense
31.34%897.22M
-0.56%710.47M
16.27%849.11M
3.41%2.9B
0.59%768.69M
-2.07%683.15M
1.76%714.48M
14.62%730.29M
7.46%2.8B
10.25%764.2M
Selling and administrative expenses
62.89%530.65M
5.87%358.4M
46.15%514.01M
3.14%1.39B
-6.75%369.29M
5.66%325.77M
-0.68%338.52M
18.06%351.71M
-5.21%1.34B
3.35%396.03M
Research and development costs
-0.86%198.2M
-13.94%189.97M
-18.93%180.65M
4.04%884M
11.03%240.5M
-14.71%199.92M
5.49%220.73M
17.65%222.85M
43.90%849.66M
25.53%216.61M
Depreciation amortization depletion
6.93%168.37M
4.43%162.1M
-0.82%154.45M
3.13%627.31M
4.85%158.9M
1.66%157.46M
2.08%155.22M
3.97%155.73M
1.52%608.28M
10.31%151.55M
-Depreciation and amortization
6.93%168.37M
4.43%162.1M
-0.82%154.45M
3.13%627.31M
4.85%158.9M
1.66%157.46M
2.08%155.22M
3.97%155.73M
1.52%608.28M
10.31%151.55M
Operating profit
-61.57%100.01M
9.79%218.97M
-173.34%-55.89M
21.60%726.63M
35.78%190.77M
50.94%260.21M
26.52%199.44M
-40.02%76.21M
16.65%597.58M
25.88%140.5M
Net non-operating interest income expense
17.25%-48.58M
23.64%-47.36M
18.77%-53.71M
17.74%-238.1M
27.11%-51.26M
17.90%-58.7M
15.58%-62.02M
10.83%-66.12M
-0.41%-289.44M
5.13%-70.32M
Non-operating interest expense
-17.25%48.58M
-23.64%47.36M
-18.77%53.71M
-17.74%238.1M
-27.11%51.26M
-17.90%58.7M
-15.58%62.02M
-10.83%66.12M
0.41%289.44M
-5.13%70.32M
Other net income (expense)
-5,948.22%-42.4M
-179,027.22%-907.16M
98.18%-213K
-78.03%-18.18M
27.20%-6.3M
49.09%-701K
121.28%507K
-633.20%-11.69M
98.29%-10.21M
97.71%-8.65M
Gain on sale of security
114.55%102K
-454.83%-1.8M
87.42%-213K
-193.11%-8.18M
-167.30%-6.3M
49.09%-701K
121.28%507K
-153.02%-1.69M
146.21%8.79M
476.83%9.35M
Special income (charges)
---42.5M
---905.36M
--0
47.37%-10M
--0
--0
--0
-900.00%-10M
96.71%-19M
95.20%-18M
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--0
----
-Less:Other special charges
--42.5M
--905.36M
----
-47.37%10M
--0
----
----
900.00%10M
-95.72%19M
-95.20%18M
Income before tax
-95.50%9.04M
-633.29%-735.55M
-6,754.62%-109.81M
57.87%470.35M
116.52%133.22M
101.78%200.81M
68.65%137.93M
-102.91%-1.6M
179.92%297.93M
118.10%61.53M
Income tax
-1,568.09%-242.42M
43.99%-17.17M
-252.64%-17.81M
23.75%-91.43M
-75.02%-57.91M
69.19%-14.53M
-26.02%-30.65M
176.15%11.67M
24.41%-119.91M
66.92%-33.09M
Earnings from equity interest net of tax
83.51%-47K
-616.67%-86K
59.76%-542K
44.83%-1.66M
96.53%-16K
-326.19%-285K
99.28%-12K
-34.03%-1.35M
69.67%-3.01M
40.36%-461K
Net income
16.91%251.41M
-526.22%-718.47M
-533.06%-92.54M
35.02%560.12M
102.98%191.12M
46.48%215.06M
61.40%168.57M
-121.06%-14.62M
285.14%414.83M
139.11%94.15M
Net income continuous Operations
16.91%251.41M
-526.22%-718.47M
-533.06%-92.54M
35.02%560.12M
102.98%191.12M
46.48%215.06M
61.40%168.57M
-121.06%-14.62M
285.14%414.83M
139.11%94.15M
Minority interest income
Net income attributable to the parent company
16.91%251.41M
-526.22%-718.47M
-533.06%-92.54M
35.02%560.12M
102.98%191.12M
46.48%215.06M
61.40%168.57M
-121.06%-14.62M
285.14%414.83M
139.11%94.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.91%251.41M
-526.22%-718.47M
-533.06%-92.54M
35.02%560.12M
102.98%191.12M
46.48%215.06M
61.40%168.57M
-121.06%-14.62M
285.14%414.83M
139.11%94.15M
Basic earnings per share
18.29%4.14
-538.06%-11.74
-560.87%-1.52
38.32%9.06
110.67%3.16
50.21%3.5
64.42%2.68
-121.10%-0.23
282.96%6.55
139.27%1.5
Diluted earnings per share
19.30%4.08
-571.49%-11.74
-560.87%-1.52
41.80%8.65
119.01%3.11
59.81%3.42
63.82%2.49
-122.12%-0.23
270.39%6.1
137.17%1.42
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 6.74%1.13B2.14%1.05B-0.46%897.84M6.12%4.07B7.53%1.09B8.52%1.05B6.95%1.02B1.03%901.98M4.78%3.83B4.10%1.01B
Operating revenue 6.74%1.13B2.14%1.05B-0.46%897.84M6.12%4.07B7.53%1.09B8.52%1.05B6.95%1.02B1.03%901.98M4.78%3.83B4.10%1.01B
Cost of revenue 15.47%128.88M5.79%116.27M9.56%104.62M2.33%445.71M20.02%128.71M9.26%111.61M12.68%109.9M-25.77%95.49M-19.41%435.58M-35.92%107.24M
Gross profit 5.71%997.23M1.70%929.44M-1.65%793.22M6.61%3.62B6.05%959.46M8.43%943.36M6.30%913.92M5.54%806.5M8.97%3.4B12.42%904.69M
Operating expense 31.34%897.22M-0.56%710.47M16.27%849.11M3.41%2.9B0.59%768.69M-2.07%683.15M1.76%714.48M14.62%730.29M7.46%2.8B10.25%764.2M
Selling and administrative expenses 62.89%530.65M5.87%358.4M46.15%514.01M3.14%1.39B-6.75%369.29M5.66%325.77M-0.68%338.52M18.06%351.71M-5.21%1.34B3.35%396.03M
Research and development costs -0.86%198.2M-13.94%189.97M-18.93%180.65M4.04%884M11.03%240.5M-14.71%199.92M5.49%220.73M17.65%222.85M43.90%849.66M25.53%216.61M
Depreciation amortization depletion 6.93%168.37M4.43%162.1M-0.82%154.45M3.13%627.31M4.85%158.9M1.66%157.46M2.08%155.22M3.97%155.73M1.52%608.28M10.31%151.55M
-Depreciation and amortization 6.93%168.37M4.43%162.1M-0.82%154.45M3.13%627.31M4.85%158.9M1.66%157.46M2.08%155.22M3.97%155.73M1.52%608.28M10.31%151.55M
Operating profit -61.57%100.01M9.79%218.97M-173.34%-55.89M21.60%726.63M35.78%190.77M50.94%260.21M26.52%199.44M-40.02%76.21M16.65%597.58M25.88%140.5M
Net non-operating interest income expense 17.25%-48.58M23.64%-47.36M18.77%-53.71M17.74%-238.1M27.11%-51.26M17.90%-58.7M15.58%-62.02M10.83%-66.12M-0.41%-289.44M5.13%-70.32M
Non-operating interest expense -17.25%48.58M-23.64%47.36M-18.77%53.71M-17.74%238.1M-27.11%51.26M-17.90%58.7M-15.58%62.02M-10.83%66.12M0.41%289.44M-5.13%70.32M
Other net income (expense) -5,948.22%-42.4M-179,027.22%-907.16M98.18%-213K-78.03%-18.18M27.20%-6.3M49.09%-701K121.28%507K-633.20%-11.69M98.29%-10.21M97.71%-8.65M
Gain on sale of security 114.55%102K-454.83%-1.8M87.42%-213K-193.11%-8.18M-167.30%-6.3M49.09%-701K121.28%507K-153.02%-1.69M146.21%8.79M476.83%9.35M
Special income (charges) ---42.5M---905.36M--047.37%-10M--0--0--0-900.00%-10M96.71%-19M95.20%-18M
-Less:Impairment of capital assets --------------0------------------0----
-Less:Other special charges --42.5M--905.36M-----47.37%10M--0--------900.00%10M-95.72%19M-95.20%18M
Income before tax -95.50%9.04M-633.29%-735.55M-6,754.62%-109.81M57.87%470.35M116.52%133.22M101.78%200.81M68.65%137.93M-102.91%-1.6M179.92%297.93M118.10%61.53M
Income tax -1,568.09%-242.42M43.99%-17.17M-252.64%-17.81M23.75%-91.43M-75.02%-57.91M69.19%-14.53M-26.02%-30.65M176.15%11.67M24.41%-119.91M66.92%-33.09M
Earnings from equity interest net of tax 83.51%-47K-616.67%-86K59.76%-542K44.83%-1.66M96.53%-16K-326.19%-285K99.28%-12K-34.03%-1.35M69.67%-3.01M40.36%-461K
Net income 16.91%251.41M-526.22%-718.47M-533.06%-92.54M35.02%560.12M102.98%191.12M46.48%215.06M61.40%168.57M-121.06%-14.62M285.14%414.83M139.11%94.15M
Net income continuous Operations 16.91%251.41M-526.22%-718.47M-533.06%-92.54M35.02%560.12M102.98%191.12M46.48%215.06M61.40%168.57M-121.06%-14.62M285.14%414.83M139.11%94.15M
Minority interest income
Net income attributable to the parent company 16.91%251.41M-526.22%-718.47M-533.06%-92.54M35.02%560.12M102.98%191.12M46.48%215.06M61.40%168.57M-121.06%-14.62M285.14%414.83M139.11%94.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.91%251.41M-526.22%-718.47M-533.06%-92.54M35.02%560.12M102.98%191.12M46.48%215.06M61.40%168.57M-121.06%-14.62M285.14%414.83M139.11%94.15M
Basic earnings per share 18.29%4.14-538.06%-11.74-560.87%-1.5238.32%9.06110.67%3.1650.21%3.564.42%2.68-121.10%-0.23282.96%6.55139.27%1.5
Diluted earnings per share 19.30%4.08-571.49%-11.74-560.87%-1.5241.80%8.65119.01%3.1159.81%3.4263.82%2.49-122.12%-0.23270.39%6.1137.17%1.42
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More